Top

Endocrine

Published in:

01-01-2018 | Review

Adrenal myelolipoma: a comprehensive review

Authors: Ábel Decmann, Pál Perge, Miklós Tóth, Peter Igaz

Published in: Endocrine | Issue 1/2018

Abstract

Introduction

Adrenal myelolipoma is an invariably benign neoplasm of the adrenal gland that is the second most common primary adrenal incidentaloma following adrenocortical adenomas. It is composed of elements of adipose tissue and extramedullary hematopoiesis. Hypotheses on stem cells and hormonal factors have been formulated regarding its pathogenesis that is still obscure. Despite its benign behavior, adrenal myelolipoma is clinically relevant as it might cause significant difficulties in the differential diagnosis of adrenal tumors.

Methods

We have reviewed 420 cases reported between 1957 and 2017 on adrenal myelolipoma retrieved from PubMed and Scopus databases and also 20 of our case series to provide a comprehensive analysis of their pathology, epidemiological and clinical features.

Results and Conclusions

The average age for its diagnosis was 51 years, and no gender difference was observed. The average size of tumors was 10.2 cm. Congenital adrenal hyperplasia was associated to 10% of all cases analyzed, while other adrenal hypersecretory disorders (cortisol, aldosterone) were found in 7.5% of cases. Computed tomography and magnetic resonance imaging can be reliably used for its differential diagnosis. If the diagnosis of an adrenal myelolipoma is unambiguous, and no associated symptoms or hormonal activity are established, surgical intervention is usually not necessary.

Available only for authorised users

A.K. Lam, Update on adrenal tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr. Pathol. 1–15 (2017). https://doi.org/10.1007/s12022-017-9484-5

C.A. Olsson, R.J. Krane, R.C. Klugo, S.M. Selikowitz, Adrenal myelolipoma. Surgery 73, 665–670 (1973)PubMed

J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am. J. Roentgenol. 190, 1163–1168 (2008). https://doi.org/10.2214/AJR.07.2799 CrossRef

X. Bin, Y. Qing, W. Linhui, G. Li, S. Yinghao, Adrenal incidentalomas: Experience from a retrospective study in a Chinese population. J. Urol. 29, 270–274 (2011). https://doi.org/10.1016/j.urolonc.2009.03.027

F. Mantero, A.M. Masini, G. Opocher, M. Giovagnetti, G. Arnaldi, Tumors, on behalf of the N.I.S.G. on A., Adrenal incidentaloma: An overview of hormonal data from the National Italian Study Group. Horm. Res. 47, 284–289 (1997). https://doi.org/10.1159/000185478 CrossRefPubMed

Y. Minamiya, S. Abo, M. Kitamura, K. Izumi, Mediastinal extraadrenal myelolipoma: report of a case. Surg. Today 27, 971–972 (1997)CrossRefPubMed

Y. Zeng, Q. Ma, L. Lin, P. Fu, Y. Shen, Q.-Y. Luo, L.-H. Zhao, J.-H. Mou, H.-L. Xiao, Giant myelolipoma in the spleen: A rare case report and literature review. Int. J. Surg. Pathol. 24, 177–180 (2016). https://doi.org/10.1177/1066896915617027 CrossRefPubMed

M. Ghaouti, K. Znati, A. Jahid, F. Zouaidia, Z. Bernoussi, N. Mahassini, Renal myelolipoma: a rare extra-adrenal tumor in a rare site: a case report and review of the literature. J. Med. Case Rep. 7, 92 (2013). https://doi.org/10.1186/1752-1947-7-92 CrossRefPubMedPubMedCentral

M. Sundaram, T. Bauer, A. von Hochstetter, H. Ilaslan, M. Joyce, Intraosseous myelolipoma. Skelet. Radiol. 36, 1181–1184 (2007). https://doi.org/10.1007/s00256-007-0347-x CrossRef

10.

M. Krismann, G. Reichle, K.M. Müller, [Thoracic bilateral myelolipoma]. Pneumologie 47, 501–503 (1993)PubMed

11.

S.A. George, M.T. Manipadam, R. Thomas, Primary myelolipoma presenting as a nasal cavity polyp: a case report and review of the literature. J. Med. Case Rep. 6, 127 (2012). https://doi.org/10.1186/1752-1947-6-127 CrossRefPubMedPubMedCentral

12.

S.H. Stein, F. Latour, S.S. Frost, Myelolipoma arising from ectopic adrenal cortex: case report and review of the literature. Am. J. Gastroenterol. 81, 999–1001 (1986)PubMed

13.

S.J. Cina, B.M. Gordon, N.S. Curry, Ectopic adrenal myelolipoma presenting as a splenic mass. Arch. Pathol. Lab. Med. 119, 561–563 (1995)PubMed

14.

S.J. Newman, K. Inzana, W. Chickering, Extradural myelolipoma in a dog. J. Vet. Diagn. Investig. 12, 71–74 (2000). https://doi.org/10.1177/104063870001200115 CrossRef

15.

G. Storms, G. Janssens, Intraocular myelolipoma in a dog. Vet. Ophthalmol. 16, 183–187 (2013). https://doi.org/10.1111/vop.12059 CrossRefPubMed

16.

Taher, A., Vichinsky, E., Musallam, K., Cappellini, M.D., Viprakasit, V., Weatherall, S.D.: Guidelines for the management of non transfusion dependent thalassaemia (NTDT). Thalassaemia International Federation (2013). https://www.ncbi.nlm.nih.gov/books/NBK190453/

17.

M.R. Fowler, R.B. Williams, J.M. Alba, C.R. Byrd, Extra-adrenal myelolipomas compared with extramedullary hematopoietic tumors: a case of presacral myelolipoma. Am. J. Surg. Pathol. 6, 363–374 (1982)CrossRefPubMed

18.

Chen, K.T.K., Felix, E.L., Flam, M.S.: Extraadrenal myelolipoma. Am. J. Clin. Pathol. 78, 386–389 (1982)

19.

R. Sanders, N. Bissada, N. Curry, B. Gordon, Clinical spectrum of adrenal myelolipoma: Analysis of eight tumors in seven patients. J. Urol. 153, 1791–1793 (1995). https://doi.org/10.1016/S0022-5347(01)67307-5 CrossRefPubMed

20.

V.G. Shenoy, A. Thota, R. Shankar, M.G. Desai, Adrenal myelolipoma: Controversies in its management. Indian. J. Urol. 31, 94–101 (2015). https://doi.org/10.4103/0970-1591.152807

21.

S. De Navasquez, Case of myelo-lipoma (bone-marrow, heterotopia) pf suprarenal gland. Guys. Hosp. Rep. 88, 237–240 (1935)

22.

K.-C. Chang, P.-I. Chen, Z.-H. Huang, Y.-M. Lin, P.-L. Kuo, Adrenal myelolipoma with translocation (3;21)(q25; p11). Cancer Genet. Cytogenet 134, 77–80 (2002). https://doi.org/10.1016/S0165-4608(01)00592-1 CrossRefPubMed

23.

E. Bishop, J.N. Eble, L. Cheng, M. Wang, D.R. Chase, A. Orazi, D.P. O’Malley, Adrenal myelolipomas show nonrandom X-chromosome inactivation in hematopoietic elements and fat: Support for a clonal origin of myelolipomas. Am. J. Surg. Pathol. 30, 838–843 (2006). https://doi.org/10.1097/01.pas.0000202044.05333.17 CrossRefPubMed

24.

C. Feng, H. Jiang, Q. Ding, H. Wen, Adrenal myelolipoma: A mingle of progenitor cells? Med. Hypotheses 80, 819–822 (2013). https://doi.org/10.1016/j.mehy.2013.03.021 CrossRefPubMed

25.

H. Selye, H. Stone, Hormonally induced transformation of adrenal into myeloid tissue. Am. J. Pathol. 26, 211–233 (1950)PubMedPubMedCentral

26.

S.C. Sieber, N.A. Gelfman, R. Dandurand, F. Braza, Ectopic ACTH and adrenal myelolipoma. Conn. Med. 53, 7–10 (1989)PubMed

27.

H. Hagiwara, T. Usui, T. Kimura, T. Tagami, M. Naruse, S. Minamiguchi, T. Kato, H. Okuno, A. Shimatsu, Lack of ACTH and androgen receptor expression in a giant adrenal myelolipoma associated with 21-hydroxylase deficiency. Endocr. Pathol. 19, 122–127 (2008). https://doi.org/10.1007/s12022-008-9034-2 CrossRefPubMed

28.

I. Motta, L. Boiocchi, P. Delbini, M. Migone De Amicis, E. Cassinerio, D. Dondossola, G. Rossi, M.D: Cappellini, A giant adrenal myelolipoma in a beta-thalassemia major patient: Does ineffective erythropoiesis play a role? Am. J. Hematol. 91, 1281–1282 (2016). https://doi.org/10.1002/ajh.24446 CrossRefPubMed

29.

B.P. Rubin, K.H. Allison, G.N. Mann, T.H. Norwood, An unusual case of multiple giant myelolipomas: Clinical and pathogenetic implications. Endocr. Pathol. 14, 93–100 (2003)CrossRefPubMed

30.

Merchant, S.H., Herman, C.M., Amin, M.B., Ro, J.Y., Troncoso, P.: Myelolipoma associated with adrenal ganglioneuroma. Arch. Pathol. Lab. Med. 126, 736–737 (2002)

31.

H. Lu, M. Gan, H. Chen, S. Huang, Adrenal myelolipoma within myxoid cortical adenoma associated with Conn’s syndrome. J. Zhejiang Univ. Sci. B. 9, 500–505 (2008). https://doi.org/10.1631/jzus.B0720014 PubMedPubMedCentral

32.

U. Kumar, S. Priyadarshi, V. Tomar, R.R. Vohra, Adrenal myelolipoma with osseous metaplasia and hypercortisolism. Urol. Ann. 9, 71–73 (2017). https://doi.org/10.4103/0974-7796.198841 CrossRefPubMedPubMedCentral

33.

R. Armand, A.R. Cappola, R.B. Horenstein, C.B. Drachenberg, H. Sasano, J.C. Papadimitriou, Adrenal cortical adenoma with excess black pigment deposition, combined with myelolipoma and clinical Cushing’s syndrome: A case report and review of the literature. Int. J. Surg. Pathol. 12, 57–61 (2004). https://doi.org/10.1177/106689690401200111 CrossRefPubMed

34.

B.F. Schwartz, L. Wasson, Hibernoma arising from the adrenal gland. Urology 61, 1035 (2003). https://doi.org/10.1016/S0090-4295(02)02586-4 CrossRefPubMed

35.

I.A. Cardinalli, A.G. de Oliveira-Filho, M.J. Mastellaro, R.C. Ribeiro, S.S. Aguiar, A unique case of synchronous functional adrenocortical adenoma and myelolipoma within the ectopic adrenal cortex in a child with Beckwith–Wiedemann syndrome. Pathol. Res. Pract. 208, 189–194 (2012). https://doi.org/10.1016/j.prp.2011.12.011 CrossRefPubMed

36.

M.C. Sebastià, M.O. Pérez-Molina, A. Alvarez-Castells, S. Quiroga, E. Pallisa, CT evaluation of underlying cause in spontaneous subcapsular and perirenal hemorrhage. Eur. Radiol. 7, 686–690 (1997). https://doi.org/10.1007/BF02742926 CrossRefPubMed

37.

G. Low, H. Dhliwayo, D.J. Lomas, Adrenal neoplasms. Clin. Radiol. 67, 988–1000 (2012). https://doi.org/10.1016/j.crad.2012.02.005 CrossRefPubMed

38.

K.Y. Lam, C.Y. Lo, Adrenal lipomatous tumours: a 30 year clinico- pathological experience at a single institution. J. Clin. Pathol. 54, 707–712 (2001)CrossRefPubMedPubMedCentral

39.

A.K. Lam, Lipomatous tumours in adrenal gland: WHO updates and clinical implications. Endocr. Relat. Cancer 24, R65–R79 (2017). https://doi.org/10.1530/ERC-16-0564 CrossRefPubMed

40.

M. Han, A.L. Burnett, E.K. Fishman, F.F. Marshall, The natural history and treatment of adrenal myelolipoma. J. Urol. 157, 1213–1216 (1997). https://doi.org/10.1016/S0022-5347(01)64926-7 CrossRefPubMed

41.

Campbell, M.J., Obasi, M., Wu, B., Corwin, M.T., Fananapazir, G.: The radiographically diagnosed adrenal myelolipoma: what do we really know? Endocrine. 1–6 (2017). doi:https://doi.org/10.1007/s12020-017-1410-6

42.

H.-P. Liu, W.-Y. Chang, S.-T. Chien, C.-W. Hsu, Y.-C. Wu, W.-C. Kung, C.-M. Su, P.-H. Liu, Intra-abdominal bleeding with hemorrhagic shock: a case of adrenal myelolipoma and review of literature. BMC Surg. 17, 74 (2017). https://doi.org/10.1186/s12893-017-0270-6 CrossRefPubMedPubMedCentral

43.

A.A. Reza-Albarran, F.J. Gomez-Perez, J.C. Lopez, M. Herrera, A. Gamboa-Dominguez, C. Keirns, A. Aranda, J.A. Rull, Myelolipoma: A new adrenal finding in Carney’s complex? Endocr. Pathol. 10, 251–257 (1999)CrossRefPubMed

44.

P. Kalafatis, Bilateral giant adrenal myelolipoma and polycystic ovarian disease. Urol. Int. 63, 139–143 (1999)CrossRefPubMed

45.

M. Yoshioka, K. Fujimori, M. Wakasugi, N. Yamazaki, M. Kuroki, T. Tsuchida, H. Seki, M. Sekiya, T. Tamura, Cushing’s disease associated with adrenal myelolipoma, adrenal calcification and thyroid cancer. Endocr. J. 41, 461–466 (1994)CrossRefPubMed

46.

S. Banik, P.S. Hasleton, R.L. Lyon, An unusual variant of multiple endocrine neoplasia syndrome: a case report. Histopathology 8, 135–144 (1984)CrossRefPubMed

47.

I. Maschler, E. Rosenmann, E.N. Ehrenfeld, Ectopic functioning adrenocortico-myelolipoma in longstanding Nelson’s syndrome. Clin. Endocrinol. (Oxf.). 10, 493–7 (1979)CrossRefPubMed

48.

F. Gemmel, H. Bruinsma, P. Oomen, J. Collins, PET/CT incidental detection of bilateral adrenal myelolipomas in a patient with a huge maxillary sinus carcinoma. Clin. Nucl. Med. 35, 132–133 (2010). https://doi.org/10.1097/RLU.0b013e3181c7c007 CrossRefPubMed

49.

V. Ludwig, M.H. Rice, W.H. Martin, M.C. Kelley, D. Delbeke, 2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in a giant adrenal myelolipoma. Mol. Imaging Biol. 4, 355–8 (2002)CrossRefPubMed

50.

P. Boraschi, G. Braccini, R. Gigoni, F. Cartei, A. Campatelli, A. Di Vito, G. Perri, [Adrenal myelolipomas: their magnetic resonance assessment]. Clin. Ter. 147, 549–557 (1996)PubMed

51.

Musante, F., Derchi, L.E., Bazzocchi, M., Avataneo, T., Gandini, G., Pozzi Mucelli, R.S.: MR imaging of adrenal myelolipomas. J. Comput. Assist. Tomogr. 15, 111–114 (1991)

52.

D.J. Wale, K.K. Wong, B.L. Viglianti, D. Rubello, M.D. Gross, Contemporary imaging of incidentally discovered adrenal masses. Biomed. Pharmacother. 87, 256–262 (2017). https://doi.org/10.1016/j.biopha.2016.12.090 CrossRefPubMed

53.

M. Fassnacht, M. Kroiss, B. Allolio, Update in Adrenocortical Carcinoma. J. Clin. Endocrinol. Metab. 98, 4551–4564 (2013). https://doi.org/10.1210/jc.2013-3020 CrossRefPubMed

54.

M.L. Nunes, A. Rault, J. Teynie, N. Valli, M. Guyot, D. Gaye, G. Belleannee, A. Tabarin, 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning. World J. Surg. 34, 1506–1510 (2010). https://doi.org/10.1007/s00268-010-0576-3 CrossRefPubMed

55.

M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev, A. Tabarin, M. Terzolo, S. Tsagarakis, O.M. Dekkers, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175, G1–G34 (2016). https://doi.org/10.1530/EJE-16-0467 CrossRefPubMed

56.

Zhong, Y., Shen, Y., Pan, J., Wang, Y., An, Y., Guo, A., Ma, L., Ye, H., Wang, H.: Renal epithelioid angiomyolipoma: MRI findings. Radiol. Med. (2017). doi:https://doi.org/10.1007/s11547-017-0788-9

57.

S. Krishna, C.A. Murray, M.D. McInnes, R. Chatelain, M. Siddaiah, O. Al-Dandan, S. Narayanasamy, N. Schieda, CT imaging of solid renal masses: pitfalls and solutions. Clin. Radiol. 72, 708–721 (2017). https://doi.org/10.1016/j.crad.2017.05.003 CrossRefPubMed

58.

W.D. Craig, J.C. Fanburg-Smith, L.R. Henry, R. Guerrero, J.H. Barton, Fat-containing lesions of the retroperitoneum: Radiologic-pathologic correlation. RadioGraphics 29, 261–290 (2009). https://doi.org/10.1148/rg.291085203 CrossRefPubMed

59.

M. Terzolo, S. Bovio, A. Pia, G. Reimondo, A. Angeli, Management of adrenal incidentaloma. Best. Pract. Res. Clin. Endocrinol. Metab. 23, 233–243 (2009). https://doi.org/10.1016/j.beem.2009.04.001 CrossRefPubMed

60.

R. Libè, C. Dall’Asta, L. Barbetta, A. Baccarelli, P. Beck-Peccoz, B. Ambrosi, Long-term follow-up study of patients with adrenal incidentalomas. Eur. J. Endocrinol. 147, 489–494 (2002)CrossRefPubMed

61.

M. Zeiger, G. Thompson, Q.-Y. Duh, A. Hamrahian, P. Angelos, D. Elaraj, E. Fishman, J. Kharlip, American Association of Clinical Endocrinologists, American Association of Endocrine Surgeons: American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: Executive Summary of Recommendations. Endocr. Pract. 15, 450–453 (2009). https://doi.org/10.4158/EP.15.5.450 CrossRefPubMed

62.

M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, A.M.E. Position, Statement on adrenal incidentaloma. Eur. J. Endocrinol. 164, 851–870 (2011). https://doi.org/10.1530/EJE-10-1147 CrossRefPubMed

63.

S. Yamashita, K. Ito, K. Furushima, J. Fukushima, S. Kameyama, Y. Harihara, Laparoscopic versus open adrenalectomy for adrenal myelolipoma. Ann. Med. Surg. 3, 34–38 (2014). https://doi.org/10.1016/j.amsu.2014.04.001 CrossRef

64.

R. Chaudhary, A. Deshmukh, K. Singh, R. Biswas, Is size really a contraindication for laparoscopic resection of giant adrenal myelolipomas? BMJ. Case Rep. 2016, bcr2016215048 (2016). https://doi.org/10.1136/bcr-2016-215048 CrossRefPubMedPubMedCentral

65.

A. Agrusa, G. Romano, G. Frazzetta, D. Chianetta, V. Sorce, G. Di Buono, G. Gulotta, Laparoscopic adrenalectomy for large adrenal masses: Single team experience. Int. J. Surg. 12, S72–S74 (2014). https://doi.org/10.1016/j.ijsu.2014.05.050 CrossRefPubMed

66.

A.K. Hemal, A. Singh, N.P. Gupta, Whether adrenal mass more than 5 cm can pose problem in laparoscopic adrenalectomy? An evaluation of 22 patients. World J. Urol. 26, 505–508 (2008). https://doi.org/10.1007/s00345-008-0270-3 CrossRefPubMed

67.

X. Shen, Y. Qiu, Y. Zheng, S. Zhang, Retroperitoneal laparoscopic liposuction for large adrenal myelolipomas: A report of nine cases. J. Laparoendosc. Adv. Surg. Tech. 22, 578–580 (2012). https://doi.org/10.1089/lap.2012.0113 CrossRef

68.

Nakajo, M., Onohara, S., Shinmura, K., Fujiyoshi, F., Nakajo, M.: Embolization for spontaneous retroperitoneal hemorrhage from adrenal myelolipoma. Radiat. Med. 21, 214–219 (2003)

69.

S.M. Chng, M.B.K. Lin, F.C. Ng, H.C. Chng, T.K. Khoo, Adrenal myelolipoma presenting with spontaneous retroperitoneal haemorrhage demonstrated on computed tomography and angiogram—a case report. Ann. Acad. Med. Singap. 31, 228–230 (2002)PubMed

Title: Adrenal myelolipoma: a comprehensive review
Authors: Ábel Decmann
Pál Perge
Miklós Tóth
Peter Igaz
Publication date: 01-01-2018
Publisher: Springer US
Published in: Endocrine / Issue 1/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-017-1473-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results and Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Erratum to: Chronic hyperglycemia affects bone metabolism in adult zebrafish scale model

Prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): what’s better?

MicroRNA-326 contributes to autoimmune thyroiditis by targeting the Ets-1 protein

MKRN3 levels in girls with central precocious puberty and correlation with sexual hormone levels: a pilot study

Decreased miR-17-92 cluster expression level in serum and granulocytes preceding onset of antithyroid drug-induced agranulocytosis

Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage